Saturday 17 October 2026
Export SCLX’s income statement to Excel — free account
Scilex Holding Company
SCLX Healthcare Drug Manufacturers General
Scilex Holding Company’s revenue for fiscal 2025 (year ended December 2025) was $30.3 million, down 46.5% from fiscal 2024. In the quarter to June 2026, revenue fell 22.8%, EPS fell 124.4%, free cash flow fell 203.8% and total debt rose 102.7%, each against the same quarter a year earlier.
2.83
0.01
+0.35%
Follow SCLX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 6 | 4 | 4 | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Altman Z-Score |
(7.96) | (13.45) | (11.80) | (3.80) | 340.70 | (8.05) | — | — | — | — |
P/S ratio |
2.77 | 1.65 | 3.54 | 11.69 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Altman Z″-Score (non-manufacturers) |
(22.99) | (41.88) | (36.61) | (18.49) | (22.43) | (30.94) | (28.02) | (1,192.57) | — | — |
P/FCF ratio |
22.96 | 4.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Beneish M-Score |
(7.77) | (7.30) | (7.64) | (1.83) | — | (6.16) | — | — | — | — |
P/Operating CF |
(4.80) | 36.85 | (30.74) | (613.22) | (29.75) | (29.72) | (2,848,373.08) | (2,848,373.08) | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 12.27 | 0.00 | 0.00 | 198,015.24 | 198,015.24 | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 198,015.24 | 198,015.24 | — | — |
EV/Sales |
5.19 | 2.22 | 5.89 | 11.78 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
EV/Operating CF |
41.14 | 6.50 | (13.29) | (21.08) | (33.54) | (33.51) | 0.00 | 0.00 | — | — |
EV/FCF |
42.97 | 6.51 | (13.27) | (21.07) | (33.54) | (33.51) | 0.00 | 0.00 | — | — |
Quick Ratio |
0.05 | 0.11 | 0.15 | 0.52 | 0.52 | 0.11 | 0.11 | 0.17 | 0.17 | — |
Current Ratio |
0.08 | 0.16 | 0.19 | 0.66 | 0.66 | 0.14 | 0.14 | 0.17 | 0.17 | — |
Net Debt/EBITDA |
(0.27) | (0.40) | (1.03) | 0.05 | 0.00 | (5.35) | (4.75) | 0.00 | (15.00) | — |
Debt/Assets |
22.81% | 37.52% | 107.03% | 0.00% | 0.00% | 171.29% | 198.57% | 0.00% | 62.66% | 0.00% |
Debt/Equity |
(0.39) | (0.18) | (0.63) | 0.00 | 0.00 | (0.60) | (0.69) | 0.00 | 6.68 | — |
Asset Turnover |
0.13 | 0.58 | 0.50 | 0.46 | 0.00 | 0.80 | 0.00 | 118.10 | 0.00 | — |
Operating CF/Net income |
(0.01) | (0.27) | 0.12 | 0.91 | 0.91 | 0.32 | 0.32 | 0.66 | 0.21 | — |
Capex/Depreciation |
0.00 | 0.00 | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Interest Coverage |
(30.20) | (42.48) | (98.72) | (5.27) | — | (3.05) | (65.50) | (2.69) | — | — |
| 199.06% | 39.83% | 244.29% | 24.90% | 0.00% | 79.00% | 0.00% | (254,112.30%) | (33.69%) | — | |
| (175.78%) | (74.96%) | (177.79%) | (28.41%) | 0.00% | (226.35%) | 0.00% | (23,819.05%) | (6.32%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | (92.93%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
93.23% | 33.49% | 82.30% | 161.55% | 175.26% | 60.73% | 61.27% | 31,616.10% | 4.19% | — |
Average Days of Receivables |
183.92 | 170.55 | 270.16 | 203.80 | 203.80 | 166.29 | 166.29 | 0.00 | — | — |
Research and Development Expense of Revenue |
68.46% | 17.04% | 27.27% | 23.81% | 23.81% | 29.38% | 29.38% | 42.28% | — | — |
Selling, General and Administrative Expense of Revenue |
882.17% | 210.31% | 255.95% | 170.62% | 170.52% | 161.52% | 161.39% | 182.39% | 0.00% | — |
Intangible Assets out of Total Assets |
0.38 | 0.49 | 0.49 | 0.62 | 0.62 | 0.67 | 0.67 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
51.21% | 27.72% | 31.23% | 13.88% | 0.00% | 18.59% | 0.00% | 22.90% | — | — |
Graham Net Nets |
(6.42) | (2.61) | (1.37) | (0.05) | (0.33) | (0.34) | 0.00 | 0.00 | — | — |
Graham Number |
125.46 | 56.07 | 217.02 | 0.00 | 42.27 | 175.64 | 0.00 | 0.00 | — | — |
Earnings Yield |
(479.61%) | (78.63%) | (101.45%) | (5.26%) | (10.63%) | (10.64%) | 0.00% | 0.00% | — | — |
Free Cash Flow Yield |
4.36% | 20.69% | (12.52%) | (4.78%) | (3.44%) | (3.45%) | 0.00% | 0.00% | — | — |
Revenue per Share |
2.74 | 5.62 | 12.54 | 9.91 | 0.28 | 8.24 | 0.24 | 6.20 | 0.00 | — |
Operating CF per Share |
0.35 | 1.92 | (5.56) | (5.54) | (0.16) | (7.54) | (0.22) | (8.28) | 0.00 | — |
Capex per Share |
(0.01) | 0.00 | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) | 0.00 | — |
Free Cash Flow per Share |
0.33 | 1.92 | (5.56) | (5.54) | (0.16) | (7.54) | (0.22) | (8.28) | 0.00 | — |
Cash per Share |
1.00 | 0.33 | 1.05 | 0.57 | 0.02 | 1.14 | 0.03 | 0.01 | 0.00 | — |
Shareholders Equity per Share |
(19.19) | (19.15) | (46.41) | 9.44 | 0.27 | (58.92) | (1.69) | 0.00 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(19.19) | (19.15) | (46.41) | 9.44 | 0.27 | (58.92) | (1.69) | 0.00 | 0.00 | — |
Free Cash Flow |
3.68 | 19.35 | (20.74) | (21.26) | (21.26) | (28.66) | (28.66) | (31.49) | 0.00 | — |
Working Capital |
(445.29) | (218.09) | (203.60) | (15.23) | (15.23) | (146.42) | (146.42) | (0.15) | (0.15) | — |
Capital Expenditures |
(0.13) | — | (0.03) | (0.01) | (2.07) | — | — | (0.02) | — | — |
Net Current Asset Value |
(538.37) | (244.05) | (227.47) | (20.68) | (20.68) | (278.80) | (278.80) | (0.15) | (0.15) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
5.76 | 6.16 | 5.83 | 9.20 | 2.34 | 14.52 | 1.97 | 0.00 | — | — |
Cash ROIC |
(3.13%) | (12.52%) | 34.23% | (55.34%) | 0.00% | 33.31% | 44.24% | (63,995.93%) | (0.75%) | — |
Accounts Receivable Turnover |
1.45 | 1.85 | 1.67 | 2.14 | 0.00 | 2.19 | 0.00 | 0.00 | — | — |
Accounts Payable Turnover |
0.15 | 0.36 | 0.63 | 0.67 | 0.00 | 0.30 | 0.00 | 18.01 | — | — |
Inventory Turnover |
2.93 | 5.02 | 5.61 | 5.48 | 0.00 | 1.42 | 0.00 | 0.00 | — | — |
Average Days of Payables |
2,970.76 | 1,150.84 | 953.27 | 285.66 | 208.99 | 2,399.72 | 210.93 | 5.10 | — | — |
Days of Inventory on Hand |
164.92 | 53.28 | 98.09 | 46.58 | 34.08 | 257.33 | 126.15 | 0.00 | — | — |
Average Receivables |
20.84 | 30.52 | 27.92 | 17.75 | 17.75 | 14.27 | — | — | — | — |
Average Payables |
69.44 | 46.79 | 24.70 | 16.17 | 16.17 | 11.96 | 2.16 | 0.12 | — | — |
Average Inventory |
3.61 | 3.33 | 2.80 | 1.97 | 1.97 | 2.56 | — | — | — | — |
Average Assets |
228.97 | 97.13 | 93.92 | 82.23 | 82.23 | 39.07 | 39.07 | 0.20 | 0.10 | — |
Average Common Equity |
(202.20) | (182.79) | (68.35) | (93.82) | (93.82) | (111.93) | (111.93) | 0.02 | 0.02 | — |
Columns are period end dates